HLA-G and cancer: To elucidate the role of HLA‐I molecules in increased NK resistance in cancer cells, we knocked out β2 microglobulin (B2M) in MB231 and MCF7 cells using the CRISPR‐Cas9 technology (Figure S3D, Supporting Information).